You are here:
» Obstetrics: Behandling med Vedolizumab og Ustekinumab af ...
About Aarhus University
Obstetrics: Behandling med Vedolizumab og Ustekinumab af gravide kvinder med kronisk inflammatorisk tarmsygdom
Project: Research
- Julsgaard, Mette (Project manager)
- Kelsen, Jens (Participant)
- Hvas, Christian Lodberg (Participant)
- Bibby, Bo Martin (Participant)
- Uldbjerg, Niels (Participant)
- Larsen, Lone (Participant)
- Kjeldsen, Jens (Participant)
- Vind, Ida (Participant)
- Wildt, Signe (Participant)
- Munkholm, Pia (Participant)
- Grosen, Anne (Participant)
- Baumgart, Daniel C (Participant)
- Hansen, Mette Mejlby (Participant)
- Baunwall, Simon Mark Dahl (Participant)
- Vestergaard, Thea Cæcilie Viborg (Participant)
- Odense Universitets Hospital
- Hvidovre Universitets Hospital
- Køge Sygehus
- Nordsjællands Universitets Hospital - Frederikssund
- Humboldt University of Berlin
| Status | Finished |
|---|---|
| Effective start/end date | 01/10/2016 → 31/03/2020 |
Research outputs
Vedolizumab safety in pregnancy and newborn outcomes
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
ID: 129048955